In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New River Pharmaceuticals Inc.

Division of Takeda Pharmaceutical Co. Ltd.
www.nrpharma.com

Latest From New River Pharmaceuticals Inc.

Shire Targets SHP465 ADHD Resubmission 10 Years After Initial Filing

Shire says it is on track to refile its long-shelved ADHD candidate SHP465 later this year after a Phase III trial in children and adolescents turned out positively.

BioPharmaceutical Clinical Trials

Shire Finally Gets Resuscitated Adult ADHD Drug Back On Track With FDA

The 16-hour ADHD candidate SHP465 (SPD465) is being aimed at adults, but FDA wants a study in children, which will kick off in August and may allow a launch by the end of 2017, Shire says.

Clinical Trials Regulation

Financings Of The Fortnight: Spurred By U.S. JOBS Act, Biotech IPOs Flowing Steadily Now

Plus the latest financing news from Denmark’s Symphogen, ScioDerm, Esperion Therapeutics and Intrexon.

Business Strategies

Financings Of The Fortnight Follows OvaScience’s Unique Route To Going Public

Plus news on recent financial activity by Stem Cells Inc., Sanofi, Avalon Ventures and Aerpio Therapeutics.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Randal J Kirk, Pres. & CEO
    Krish S Krishnan, CFO & COO
    John Thottathil, PhD, CSO
  • Contact Info
  • New River Pharmaceuticals Inc.
    Phone: (540) 633-7978
    1881 Grove Ave.
    Radford, VA 24141
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register